{
    "organizations": [],
    "uuid": "4484f0075083c1ea8c04a9bd51553e6d4fe13f16",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eleven-biotherapeutics-announces-c/brief-eleven-biotherapeutics-announces-corporate-name-change-to-sesen-bio-idUSFWN1SN0IX",
    "ord_in_thread": 0,
    "title": "BRIEF-Eleven Biotherapeutics Announces Corporate Name Change To Sesen Bio",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 16 (Reuters) - Eleven Biotherapeutics Inc:\n* ELEVEN BIOTHERAPEUTICS ANNOUNCES CORPORATE NAME CHANGE TO SESEN BIO\n* ELEVEN BIOTHERAPEUTICS INC - SESEN BIO WILL TRADE UNDER NEW NASDAQ TICKER SYMBOL “SESN,” EFFECTIVE ON MAY 17, 2018 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-16T18:36:00.000+03:00",
    "crawled": "2018-05-17T14:21:47.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "eleven",
        "biotherapeutics",
        "inc",
        "eleven",
        "biotherapeutics",
        "announces",
        "corporate",
        "name",
        "change",
        "sesen",
        "bio",
        "eleven",
        "biotherapeutics",
        "inc",
        "sesen",
        "bio",
        "trade",
        "new",
        "nasdaq",
        "ticker",
        "symbol",
        "sesn",
        "effective",
        "may",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}